State Street Corp Regeneron Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 4,789,659 shares of REGN stock, worth $2.85 Billion. This represents 0.13% of its overall portfolio holdings.

Number of Shares

4,789,659

Previous 4,832,239 0.88%

Holding current value

$2.85 Billion

Previous $3.44 Billion 11.75%

% of portfolio

0.13%

Previous 0.14%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$634.14 - $744.83 $27 Million - $31.7 Million	-42,580 Reduced 0.88%	4,789,659 $3.04 Billion
Q4 2024 Feb 14, 2025	SELL	$701.85 - $1046.91 $49.2 Million - $73.5 Million	-70,165 Reduced 1.43%	4,832,239 $3.44 Billion
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $62.8 Million - $73.6 Million	61,277 Added 1.27%	4,902,404 $5.15 Billion
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $371,827 - $450,970	-421 Reduced 0.01%	4,841,127 $5.09 Billion
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $53.9 Million - $59.3 Million	-59,703 Reduced 1.22%	4,841,548 $4.66 Billion
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $55.9 Million - $63.6 Million	72,145 Added 1.49%	4,901,251 $4.3 Billion
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $112 Million - $137 Million	-161,764 Reduced 3.24%	4,829,106 $3.97 Billion
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $68.1 Million - $80.8 Million	97,254 Added 1.99%	4,990,870 $3.59 Billion
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $45.8 Million - $55.6 Million	-67,269 Reduced 1.36%	4,893,616 $4.02 Billion
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $64.1 Million - $69.6 Million	-90,874 Reduced 1.8%	4,960,885 $3.58 Billion
Q3 2022 Nov 15, 2022	SELL	$573.97 - $724.32 $45.3 Million - $57.1 Million	-78,876 Reduced 1.54%	5,051,759 $3.48 Billion
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $2.83 Million - $3.82 Million	5,168 Added 0.1%	5,130,635 $3.03 Billion
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $194 Million - $227 Million	325,645 Added 6.78%	5,125,467 $3.58 Billion
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $86.9 Million - $107 Million	159,817 Added 3.44%	4,799,822 $3.03 Billion
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $70.8 Million - $84 Million	123,289 Added 2.73%	4,640,005 $2.81 Billion
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $14.5 Million - $17.1 Million	-30,585 Reduced 0.67%	4,516,716 $2.52 Billion
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $64.4 Million - $79 Million	-144,086 Reduced 3.07%	4,547,301 $2.15 Billion
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $16.2 Million - $20.6 Million	33,849 Added 0.73%	4,691,387 $2.27 Billion
Q3 2020 Nov 10, 2020	BUY	$544.75 - $658.21 $57.7 Million - $69.7 Million	105,873 Added 2.33%	4,657,538 $2.61 Billion
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $461 Million - $602 Million	934,332 Added 25.83%	4,551,665 $2.84 Billion
Q1 2020 May 11, 2020	BUY	$336.18 - $494.43 $1.22 Billion - $1.79 Billion	3,617,333 New	3,617,333 $1.77 Billion

Others Institutions Holding REGN

# of Institutions

1,470

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $63.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Regeneron Pharmaceuticals, Inc. Transaction History